39 reports of this reaction
1.8% of all OMEPRAZOLE, SODIUM BICARBONATE reports
#10 most reported adverse reaction
INCORRECT PRODUCT ADMINISTRATION DURATION is the #10 most commonly reported adverse reaction for OMEPRAZOLE, SODIUM BICARBONATE, manufactured by CVS Pharmacy. There are 39 FDA adverse event reports linking OMEPRAZOLE, SODIUM BICARBONATE to INCORRECT PRODUCT ADMINISTRATION DURATION. This represents approximately 1.8% of all 2,134 adverse event reports for this drug.
Patients taking OMEPRAZOLE, SODIUM BICARBONATE who experience incorrect product administration duration should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
INCORRECT PRODUCT ADMINISTRATION DURATION is a less commonly reported adverse event for OMEPRAZOLE, SODIUM BICARBONATE, but still significant enough to appear in the safety profile.
In addition to incorrect product administration duration, the following adverse reactions have been reported for OMEPRAZOLE, SODIUM BICARBONATE:
The following drugs have also been linked to incorrect product administration duration in FDA adverse event reports:
INCORRECT PRODUCT ADMINISTRATION DURATION has been reported as an adverse event in 39 FDA reports for OMEPRAZOLE, SODIUM BICARBONATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
INCORRECT PRODUCT ADMINISTRATION DURATION accounts for approximately 1.8% of all adverse event reports for OMEPRAZOLE, SODIUM BICARBONATE, making it a notable side effect.
If you experience incorrect product administration duration while taking OMEPRAZOLE, SODIUM BICARBONATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.